07/20/2026
A University of Miami Miller School of Medicine study found that combining blood-based biomarkers with specialized cognitive testing significantly improves prediction of functional decline in older adults at risk for Alzheimer’s disease, offering a more precise approach to early diagnosis and monitoring.
Combining blood biomarkers with cognitive testing improves prediction of functional decline in people at risk for Alzheimer’s disease.